TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2015

Results of a Phase II Trial of Brentuximab Vedotin for CD30+ Cutaneous T-Cell Lymphoma and Lymphomatoid Papulosis.

Madeleine Duvic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.